Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: DEF 14A Filing - Trial to be held in Nov of 2007

Apr 02, 2007 10:17AM
The 14A filing does not list Swartz as a beneficial shareholder. The list contains officers, bod members, Lincoln llc and others but no Swartz. I am sure it was just a mistake, but that is a big one.
Share
New Message
Please login to post a reply